×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| GUJARAT THEMIS BIOSYN LTD. | 361.47 | 90.62 | 358.73 | 0.83 | 4,357 | 97.7 |
| AARTI DRUGS LTD. | 5213.4 | 486.4 | 5209.6 | 5.33 | 4320 | 22.9 |
| INDRAPRASTHA MEDICAL CORP.LTD. | 3719.6 | 514.6 | 3650.6 | 5.61 | 4096 | 24.4 |
Gujarat Themis Biosyn Ltd., with Security Code 506879, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.2 | 49.6 | 39.7 | 38.9 | 42.0 | 38.8 | 34.7 | 39.5 | 37.7 | 35.9 |
| Expenses | 13.2 | 26.1 | 22.8 | 21.1 | 21.1 | 20.3 | 19.3 | 20.7 | 21.6 | 22.0 |
| Operating Profit | 14.9 | 23.5 | 16.8 | 17.7 | 20.9 | 18.6 | 15.4 | 18.9 | 16.1 | 13.9 |
| OPM % | 52.98% | 47.4% | 42.42% | 45.67% | 49.82% | 47.78% | 44.34% | 47.74% | 42.76% | 38.81% |
| Other Income | 1.4 | 1.1 | 1.0 | 1.0 | 1.0 | 0.5 | 0.3 | 0.2 | 1.3 | 0.3 |
| Interest | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Depreciation | 0.8 | 0.7 | 0.9 | 1.0 | 0.9 | 1.1 | 1.4 | 1.6 | 1.2 | 2.0 |
| Profit before tax | 15.5 | 23.8 | 16.9 | 17.7 | 20.9 | 17.9 | 14.2 | 17.4 | 16.2 | 12.1 |
| Tax % | -24.7% | -25.6% | -25.7% | -26.5% | -24.2% | -25.9% | -25.5% | -25.4% | -24.9% | 25.2% |
| Net Profit | 11.7 | 17.7 | 12.5 | 13.0 | 15.9 | 13.2 | 10.6 | 13.0 | 12.0 | 9.1 |
| EPS in Rs | 8.05 | 12.2 | 8.63 | 1.79 | 2.19 | 1.82 | 0.97 | 1.19 | 0 | 0.83 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 16% |
| 3 Years: | 4% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 66% |
| 3 Years: | 78% |
| 1 Year: | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|